+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Influence of Artificial Intelligence on Drug Discovery and Development

  • ID: 4592877
  • Report
  • July 2018
  • Region: Global
  • 15 Pages
  • Frost & Sullivan

The Genetic Technology TechVision Opportunity Engine (TOE) outlines the impact of artificial intelligence (AI) on the global drug discovery and development landscape. Berg Health’s precision medicine platforms and a clinical overview of the company’s pipeline have been profiled in the TOE. Furthermore, IP trends, research aspects, and AI-medicine strategies have also been described.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Note: Product cover images may vary from those shown

1. Recent Advances in Artificial Intelligence in Pharma

  • Artificial Intelligence - Overall Impact and Opportunity Leverage
  • AI-based Precision Medicine
  • AI-based Precision Medicine Innovation Scouting
  • AI-driven Medicine: Approaches, Features, and Targeted Areas

2. Clinical Trial Analysis and Key Contacts

  • Clinical Trial Analysis: Bergh Health’s Pipeline
  • Key Contacts
Note: Product cover images may vary from those shown